The potential role of miRNAs 21 and 199-a in early diagnosis of hepatocellular carcinoma

Gene

Volumn 575, Issue 1, 2016, Pages 66-70

  Amr, Khalda Said ^a   Ezzat, Wafaa M ^a   Elhosary, Yasser A ^a   Hegazy, Abdelfattah E ^b   Fahim, Hoda H ^b   Kamel, Refaat R ^c  

^a NATIONAL RESEARCH CENTRE   (Egypt)

^b El Sahel Teaching Hospital   (Egypt)

^c AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

HCC mir 21 mir 199 a

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 199A; MICRORNA 21; UNCLASSIFIED DRUG; MIRN199 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; EARLY DIAGNOSIS; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SERUM; TISSUE LEVEL; BIOSYNTHESIS; CARCINOMA, HEPATOCELLULAR; COMPARATIVE STUDY; GENE EXPRESSION REGULATION; HEPATITIS C, CHRONIC; LIVER NEOPLASMS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; BIOMARKERS, TUMOR; CARCINOMA, HEPATOCELLULAR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATITIS C, CHRONIC; HUMANS; LIVER NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; RNA, NEOPLASM;

EID: 84947865543     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2015.08.038     Document Type: Article

References (38)

1. Borel F., Konstantinova P., Jansen P.L. Diagnostic and therapeutic potential of miRNA signatures in patients with hepatocellular carcinoma. J. Hepatol. 2012, 56:1371-1383.
2. Bosch F.X., Ribes J., Cleries R., Diaz M. Epidemiology of hepatocellular carcinoma. Clin. Liver Dis. 2005, 9:191-211.
3. Brodersen P., Voinnet O. Revisiting the principles of microRNA target recognition and mode of action. Nat. Rev. Mol. Cell Biol. 2009, 10:141-148.
4. Calin G.A., Dumitru C.D., Shimizu M., Bichi R., Zupo S., Noch E., Aldler H., Rattan S., Keating M., Rai K., Rassenti L., Kipps T., Negrini M., Bullrich F., Croce C.M. Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:15524-15529.
5. Cortez M.A., Calin G.A. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin. Biol. Ther. 2009, 9(6):703-711.
6. Davis-Dusenbery B.N., Hata A. Mechanisms of control of microRNA biogenesis. J. Biochem. 2010, 148:381-392.
7. Desai M.D., Saroya B.S., Lockhart A.C. Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers. Expert Opin. Investig. Drugs 2013, 22(3):341-356. (Mar).
8. Donato F., Tagger A., Gelatti U., Parrinello G., Boffetta P., Albertini A., Decarli A., Trevisi P., Ribero M.L., Martelli C., Porru S., Nardi G. Alcohol and hepatocellular carcinoma: the effect of lifetime intake and hepatitis virus infections in men and women. Am. J. Epidemiol. 2002, 155:323-333.
9. Du T. Zamore PD microPrimer: the biogenesis and function of microRNA. Development 2005, 132:4645-4652.
10. El-Serag H.B., Rudolph K.L. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007, 132:2557-2576.
11. Esquela-Kerscher A., Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 2006, 6:259-269.
12. Eswaran J., Soundararajan M., Knapp S. Targeting group II PAKsin cancer and metastasis. Cancer Metastasis Rev. 2009, 28:209-217.
13. Graves P., Zeng Y. Biogenesis of mammalian microRNAs: a global view. Genomics Proteomics Bioinforma. 2012, 10:239-245.
14. Greene F.L., Page D.L., Fleming I.D., et al. AJCC Cancer Staging Manual 2002, Springer, New York. 6th ed.
15. He L., Thomson J.M., Hemann M.T., Hernando-Monge E., Mu D., Goodson S., Powers S., Cordon-Cardo C., Lowe S.W., Hannon G.J., Hammond S.M. A microRNA polycistron as a potential human oncogene. Nature 2005, 435:828-833.
16. Hung Chao-Hung, Chiu Yi-Chun, Chen Chien-Hung, Hu Tsung-Hui MicroRNAs in hepatocellular carcinoma: carcinogenesis, progression, and therapeutic target. BioMed. Res. Int. 2014, 2014. (Article ID 486407, 11 pages).
17. Huynh H., TuyenNguyen T.T., Pierce Chow K.-H., Tan P.H., Soo K.C., Tran E. Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol. 2003, 3. (article 19).
18. Jiang J., Gusev Y., Aderca I., Mettler T.A., Nagorney D.M., Brackett D.J., Roberts L.R., Schmittgen T.D. Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival. Clin. Cancer Res. 2008, 14:419-427.
19. Lanford R.E., Hildebrandt-Eriksen E.S., Petri A., et al. Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 2010, 327:198-201.
20. Lee Y.S., Dutta A. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene. Genes Dev. 2007, 21:1025-1030.
21. Lodygin D., Tarasov V., Epanchintsev A., Berking C., Knyazeva T., Körner H., et al. Inactivation of mir-34a by aberrant cpg methylation in multiple types of cancer. Cell Cycle 2008, 7:2591-2600.
22. Loffler D., Brocke-Heidrich K., Pfeifer G., et al. Interleukin-6 dependent survival of multiple myeloma cells involves the Stat3-mediated induction of microRNA-21 through a highly conserved enhancer. Blood 2007, 110:1330-1333.
23. Marquez R.T., Bandyopadhyay S., Wendlandt E.B., Keck K., Hoffer B.A., et al. Correlation between microRNA expression levels and clinical parameters associated with chronic hepatitis C viral infection in humans. Lab. Investig. 2010, 90:1727-1736.
24. Marquez Rebecca T., Wendlandt Erik, Searcey Galle Courtney, Keck Kathy, McCaffrey Anton P. MicroRNA-21 is upregulated during the proliferative phase of liver regeneration, targets Pellino-1, and inhibits NF-B. Signaling. Am. J. Physiol. Gastrointest. Liver Physiol. 2010, 298:535-541.
25. Mayr C., Hemann M.T., Bartel D.P. Disrupting the pairing between let-7 and Hmga2 enhances oncogenic transformation. Science 2007, 315:1576-1579.
26. Medina P.P., Nolde M., Slack F.J. OncomiR addiction in an in vivo model of microRNA-21-induced pre-B-cell lymphoma. Nature 2010, 467:86-90.
27. Meng F., Henson R., Wehbe-Janek H., Ghoshal K., Jacob S.T., Patel T. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology 2007, 133:647-658. (PubMed: 17681183).
28. Murakami Y., Yasuda T., Saigo K., Urashima T., Toyoda H., Okanoue T., Shimotohno K. Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and nontumorous tissues. Oncogene 2006, 25:2537-2545.
29. Papaconstantinou I., Karakatsanis A., Gazouli M., Polymeneas G., Voros D. The role of microRNAs in liver cancer. Eur. J. Gastroenterol. Hepatol. 2012, 24:223-228.
30. Qi J., Wang J., Katayama H., Sen S., Liu S.M. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma 2013, 60(135-42). (November 12).
31. Soini Y., Chia S.C., Bennett W.P., Groopman J.D., Wang J.S., DeBenedetti V.M. An aflatoxin-associated mutational hot spot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico. Carcinogenesis 1996, 17:1007-1012.
32. Song J., Gao L., Yang G., et al. MiR-199a regulates cell proliferation and survival by targeting FZD7. PLoS ONE 2014, 9(10):e110074. 10.1371/journal.pone.0110074.
33. Tomimaru Y., Eguchi H., Nagano H., et al. Circulating microRNA-21 as a novel biomarker for hepatocellular carcinoma. J. Hepatol. 2012, 56(1):167-175.
34. Ura S., Honda M., Yamashita T., Ueda T., Takatori H., Nishino R., Sunakozaka H., Sakai Y., Horimoto K., Kaneko S. Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma. Hepatology 2009, 49:1098-1112.
35. Varnholt H. The role of microRNAs in primary liver cancer. Ann. Hepatol. 2008, 7:104-113.
36. Worley A., Long M.D., Onken M.D., Harbour J.W. Micro-RNAs associated with metastasis in uveal melanoma identified by multiplexed microarray profiling. Melanoma Res. 2008, 18:184-190.
37. Yan K., Gao J., Yang T., Ma Q., Qiu X., Fan Q., et al. MicroRNA-34a inhibits the proliferation and metastasis of osteosarcoma cells both in vitro and in vivo. PLoS One 2012, 7:e33778.
38. Zhang H., Ozaki I., Mizuta T., et al. Involvement of programmed cell death 4 in transforming growth factor- beta1-induced apoptosis in human hepatocellular carcinoma. Oncogene 2006, 25:6101-6112. (PubMed: 16682950).